vs
太平洋生物科学（ASMB）与SuperCom Ltd（SPCB）财务数据对比。点击上方公司名可切换其他公司
SuperCom Ltd的季度营收约是太平洋生物科学的1.3倍（$14.2M vs $10.8M），SuperCom Ltd净利率更高（37.5% vs -85.2%，领先122.7%），太平洋生物科学同比增速更快（57.6% vs -1.5%），SuperCom Ltd自由现金流更多（$-3.6M vs $-15.2M）
该公司是一家成立于2004年的美国生物科技企业，主要研发生产基因测序相关设备，同时也开展新型实时生物观测技术相关业务。目前拥有两大核心测序平台，分别是基于零模波导特性的单分子实时测序平台，以及结合天然核苷酸无痕连接技术的结合测序平台。
Super.com是一家总部位于美国旧金山的科技公司，由侯赛因·法扎勒和施亨利联合创立。该公司主营金融服务业务，具体涵盖会员奖励计划以及旅行预订等相关服务，在出行与消费金融领域深耕发展。
ASMB vs SPCB — 直观对比
营收规模更大
SPCB
是对方的1.3倍
$10.8M
营收增速更快
ASMB
高出59.1%
-1.5%
净利率更高
SPCB
高出122.7%
-85.2%
自由现金流更多
SPCB
多$11.6M
$-15.2M
损益表 — Q3 FY2025 vs Q2 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $10.8M | $14.2M |
| 净利润 | $-9.2M | $5.3M |
| 毛利率 | — | 61.2% |
| 营业利润率 | -100.9% | 16.3% |
| 净利率 | -85.2% | 37.5% |
| 营收同比 | 57.6% | -1.5% |
| 净利润同比 | 4.3% | 79.5% |
| 每股收益（稀释后） | $-0.72 | $1.32 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASMBSPCB
| Q3 25 | $10.8M | — | ||
| Q2 25 | $9.6M | $14.2M | ||
| Q1 25 | $9.4M | — | ||
| Q4 24 | $7.4M | — | ||
| Q3 24 | $6.8M | — | ||
| Q2 24 | $8.5M | $14.4M | ||
| Q1 24 | $5.8M | — | ||
| Q2 23 | — | $14.1M |
净利润ASMBSPCB
| Q3 25 | $-9.2M | — | ||
| Q2 25 | $-10.2M | $5.3M | ||
| Q1 25 | $-8.8M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-9.6M | — | ||
| Q2 24 | $-11.2M | $3.0M | ||
| Q1 24 | $-9.1M | — | ||
| Q2 23 | — | $-2.6M |
毛利率ASMBSPCB
| Q3 25 | — | — | ||
| Q2 25 | — | 61.2% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 52.3% | ||
| Q1 24 | — | — | ||
| Q2 23 | — | 27.2% |
营业利润率ASMBSPCB
| Q3 25 | -100.9% | — | ||
| Q2 25 | -115.2% | 16.3% | ||
| Q1 25 | -105.5% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -160.1% | — | ||
| Q2 24 | -143.0% | 7.7% | ||
| Q1 24 | -185.5% | — | ||
| Q2 23 | — | -12.2% |
净利率ASMBSPCB
| Q3 25 | -85.2% | — | ||
| Q2 25 | -105.9% | 37.5% | ||
| Q1 25 | -93.6% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -140.4% | — | ||
| Q2 24 | -130.7% | 20.6% | ||
| Q1 24 | -156.9% | — | ||
| Q2 23 | — | -18.3% |
每股收益（稀释后）ASMBSPCB
| Q3 25 | $-0.72 | — | ||
| Q2 25 | $-1.33 | $1.32 | ||
| Q1 25 | $-1.17 | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-1.51 | — | ||
| Q2 24 | $-1.98 | $1.19 | ||
| Q1 24 | $-1.66 | — | ||
| Q2 23 | — | $-10.66 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $22.5M | $15.0M |
| 总债务越低越好 | — | $23.6M |
| 股东权益账面价值 | $182.7M | $37.3M |
| 总资产 | $240.0M | $65.5M |
| 负债/权益比越低杠杆越低 | — | 0.63× |
8季度趋势，按日历期对齐
现金及短期投资ASMBSPCB
| Q3 25 | $22.5M | — | ||
| Q2 25 | $24.0M | $15.0M | ||
| Q1 25 | $23.4M | — | ||
| Q4 24 | $38.3M | — | ||
| Q3 24 | $28.5M | — | ||
| Q2 24 | $19.2M | $5.7M | ||
| Q1 24 | $18.7M | — | ||
| Q2 23 | — | $1.1M |
总债务ASMBSPCB
| Q3 25 | — | — | ||
| Q2 25 | — | $23.6M | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $29.2M | ||
| Q1 24 | — | — | ||
| Q2 23 | — | $32.9M |
股东权益ASMBSPCB
| Q3 25 | $182.7M | — | ||
| Q2 25 | $18.1M | $37.3M | ||
| Q1 25 | $27.1M | — | ||
| Q4 24 | $33.4M | — | ||
| Q3 24 | $26.0M | — | ||
| Q2 24 | $34.7M | $13.8M | ||
| Q1 24 | $32.6M | — | ||
| Q2 23 | — | $3.5M |
总资产ASMBSPCB
| Q3 25 | $240.0M | — | ||
| Q2 25 | $80.8M | $65.5M | ||
| Q1 25 | $99.0M | — | ||
| Q4 24 | $119.2M | — | ||
| Q3 24 | $100.3M | — | ||
| Q2 24 | $115.3M | $49.6M | ||
| Q1 24 | $119.9M | — | ||
| Q2 23 | — | $40.8M |
负债/权益比ASMBSPCB
| Q3 25 | — | — | ||
| Q2 25 | — | 0.63× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 2.11× | ||
| Q1 24 | — | — | ||
| Q2 23 | — | 9.49× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-15.1M | $-2.2M |
| 自由现金流经营现金流 - 资本支出 | $-15.2M | $-3.6M |
| 自由现金流率自由现金流/营收 | -140.7% | -25.3% |
| 资本支出强度资本支出/营收 | 0.4% | 10.0% |
| 现金转化率经营现金流/净利润 | — | -0.41× |
| 过去12个月自由现金流最近4个季度 | — | $-14.0M |
8季度趋势，按日历期对齐
经营现金流ASMBSPCB
| Q3 25 | $-15.1M | — | ||
| Q2 25 | $-16.8M | $-2.2M | ||
| Q1 25 | $-23.4M | — | ||
| Q4 24 | $-51.1M | — | ||
| Q3 24 | $-15.2M | — | ||
| Q2 24 | $-17.1M | $-950.0K | ||
| Q1 24 | $-18.4M | — | ||
| Q2 23 | — | $-3.4M |
自由现金流ASMBSPCB
| Q3 25 | $-15.2M | — | ||
| Q2 25 | — | $-3.6M | ||
| Q1 25 | — | — | ||
| Q4 24 | $-51.1M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-17.1M | $-1.6M | ||
| Q1 24 | $-18.4M | — | ||
| Q2 23 | — | $-4.5M |
自由现金流率ASMBSPCB
| Q3 25 | -140.7% | — | ||
| Q2 25 | — | -25.3% | ||
| Q1 25 | — | — | ||
| Q4 24 | -695.2% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -200.6% | -10.8% | ||
| Q1 24 | -317.7% | — | ||
| Q2 23 | — | -31.5% |
资本支出强度ASMBSPCB
| Q3 25 | 0.4% | — | ||
| Q2 25 | 0.0% | 10.0% | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 0.4% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.2% | 4.2% | ||
| Q1 24 | 0.2% | — | ||
| Q2 23 | — | 7.4% |
现金转化率ASMBSPCB
| Q3 25 | — | — | ||
| Q2 25 | — | -0.41× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -0.32× | ||
| Q1 24 | — | — | ||
| Q2 23 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
